Sesen Bio, Inc. SESN
0.63 +0.63
Day range unavailable
52-week range unavailable
News
businesswire.com Sesen Bio Stockholders Approve Merger with Carisma Therapeutics CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that its stockholders have voted to approve all proposals, including the pending…- businesswire.com Sesen Bio Stockholders Approve Merger with Carisma Therapeutics CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that its stockholders have voted to approve all proposals, including the pending…
businesswire.com Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN) today reported operating results for the fourth quarter and full year ended December 31, 2022, and provided a business update. Business…
businesswire.com Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN) today reported operating results for the fourth quarter and full year ended December 31, 2022, and provided a business update. Business…
businesswire.com Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote “FOR” All Proposals to Approve Pending Merger With Carisma CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that leading independent proxy advisory firm Glass, Lewis & Co. (“Glass Lewis”)…
businesswire.com Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote “FOR” All Proposals to Approve Pending Merger With Carisma CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that leading independent proxy advisory firm Glass, Lewis & Co. (“Glass Lewis”)…
businesswire.com Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that Institutional Shareholder Services (“ISS”) recommends that stockholders vote…
businesswire.com Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that Institutional Shareholder Services (“ISS”) recommends that stockholders vote…
businesswire.com Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) today announced that members of its management team will host a fireside chat with members of the Carisma Therapeutics Inc.…
businesswire.com BML, One of Sesen Bio's Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that BML Investment Partners, L.P. (“BML”), one of Sesen Bio's top stockholders,…
businesswire.com Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger CAMBRIDGE, Mass. & PHILADELPHIA--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) and Carisma Therapeutics Inc. (Carisma), a privately-held, clinical stage biopharmaceutical company focused on…
businesswire.com Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger CAMBRIDGE, Mass. & PHILADELPHIA--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) and Carisma Therapeutics Inc. (Carisma), a privately-held, clinical stage biopharmaceutical company focused on…
businesswire.com Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (NASDAQ: SESN) today filed an investor presentation highlighting its value maximizing merger with Carisma Therapeutics Inc. (“Carisma”). The…
businesswire.com Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger CAMBRIDGE, Mass.--( BUSINESS WIRE )--Sesen Bio, Inc. (NASDAQ: SESN) today filed an investor presentation highlighting its value maximizing merger with Carisma Therapeutics Inc. (“Carisma”). The…
businesswire.com Sesen Bio Receives NASDAQ Delisting Notice CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”) today announced that it has received notice from the Listing Qualifications Department of The Nasdaq…- businesswire.com Sesen Bio Receives NASDAQ Delisting Notice CAMBRIDGE, Mass.--( BUSINESS WIRE )--Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”) today announced that it has received notice from the Listing Qualifications Department of The Nasdaq…
businesswire.com Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN) today issued the following statement reiterating the Company’s confidence in, and commitment to, the pending merger with Carisma…
businesswire.com Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders CAMBRIDGE, Mass.--( BUSINESS WIRE )--Sesen Bio, Inc. (Nasdaq: SESN) today issued the following statement reiterating the Company's confidence in, and commitment to, the pending merger with Carisma…
businesswire.com Investor Group Issues Letter to the Boards of Sesen Bio and Carisma Rejecting Their Apparent Attempt to Purchase Merger Support HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with their affiliates, the “Investor Group” or “we”), who own approximately 8.4% of the outstanding common stock of Sesen Bio,…
businesswire.com Investor Group Issues Letter to the Boards of Sesen Bio and Carisma Rejecting Their Apparent Attempt to Purchase Merger Support HOUSTON--( BUSINESS WIRE )--Bradley L. Radoff and Michael Torok (together with their affiliates, the “Investor Group” or “we”), who own approximately 8.4% of the outstanding common stock of Sesen…
benzinga.com Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday Gainers
benzinga.com Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session Gainers
benzinga.com S&P 500 Rises 0.5%; Crude Oil Falls Sharply U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Wednesday.
benzinga.com Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.- benzinga.com 89 Biggest Movers From Friday Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
- benzinga.com 77 Biggest Movers From Yesterday Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an…
- benzinga.com 80 Biggest Movers From Yesterday Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume.
benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 849 stocks hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 721 companies achieved new lows for the year.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 160 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 466 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 348 companies hit new 52-week lows.
- benzinga.com 23 Stocks Moving in Thursday's Pre-Market Session Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) rose 34.9% to $13.44 in pre-market trading after announcement of a proposed merger with Trump Media & Technology Group.
benzinga.com 48 Biggest Movers From Yesterday Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO and Chairman and…- benzinga.com 58 Biggest Movers From Yesterday Gainers
- benzinga.com 38 Stocks Moving In Thursday's Mid-Day Session Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares jumped 141% to $1.7950 after dropping 12% on Wednesday. Sonnet BioTherapeutics recently reported its financial results for the…
- benzinga.com 78 Biggest Movers From Friday Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
benzinga.com Stocks That Hit 52-Week Highs On Friday During Friday's morning session, 137 companies made new 52-week highs.
benzinga.com 77 Biggest Movers From Yesterday Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to engage in…- benzinga.com Stocks That Hit 52-Week Highs On Thursday This morning 94 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning session, 255 companies made new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday Tuesday morning saw 244 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday On Wednesday morning, 261 companies achieved new highs for the year.
- benzinga.com 30 Stocks Moving in Tuesday's Pre-Market Session Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 37.8% to $1.64 in pre-market trading after the company said it will receive $30 million in added payments during 2021.
- benzinga.com Earnings Scheduled For May 10, 2021 Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.
- benzinga.com 52 Weeks High Article 0.7186450125908432 Stocks That Hit 52-Week Highs On Monday Before 10 a.m. ET on Monday, 136 companies hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday This morning 533 companies reached new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday On Tuesday, 596 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Monday Monday morning saw 558 companies set new 52-week highs.